Works by Bromberg, Jacqueline


Results: 29
    1
    2

    Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.

    Published in:
    European Heart Journal, 2023, v. 44, n. 46, p. 4878, doi. 10.1093/eurheartj/ehad085
    By:
    • Scott, Jessica M;
    • Lee, Jasme;
    • Herndon, James E;
    • Michalski, Meghan G;
    • Lee, Catherine P;
    • O'Brien, Kelly A;
    • Sasso, John P;
    • Yu, Anthony F;
    • Rowed, Kylie A;
    • Bromberg, Jacqueline F;
    • Traina, Tiffany A;
    • Gucalp, Ayca;
    • Sanford, Rachel A;
    • Gajria, Devika;
    • Modi, Shanu;
    • Comen, Elisabeth A;
    • D'Andrea, Gabriella;
    • Blinder, Victoria S;
    • Eves, Neil D;
    • Peppercorn, Jeffrey M
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.

    Published in:
    International Journal of Oncology, 2018, v. 52, n. 2, p. 424, doi. 10.3892/ijo.2017.4212
    By:
    • Sonnenblick, Amir;
    • Salgado, Roberto;
    • Brohée, Sylvain;
    • Zahavi, Tamar;
    • Peretz, Tamar;
    • Van Den Eynden, Gert;
    • Rouas, Ghizlane;
    • Salmon, Asher;
    • Francis, Prudence A.;
    • Di Leo, Angelo;
    • Crown, John P.A.;
    • Viale, Giuseppe;
    • Daly, Laura;
    • Javdan, Bahar;
    • Fujisawa, Sho;
    • De Azambuja, Evandro;
    • Lieveke, Ameye;
    • Piccart, Martine J.;
    • Bromberg, Jacqueline F.;
    • Sotiriou, Christos
    Publication type:
    Article
    10
    11

    Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00487-x
    By:
    • Makhlin, Igor;
    • McAndrew, Nicholas P.;
    • Wileyto, E. Paul;
    • Clark, Amy S.;
    • Holmes, Robin;
    • Bottalico, Lisa N.;
    • Mesaros, Clementina;
    • Blair, Ian A.;
    • Jeschke, Grace R.;
    • Fox, Kevin R.;
    • Domchek, Susan M.;
    • Matro, Jennifer M.;
    • Bradbury, Angela R.;
    • Feldman, Michael D.;
    • Hexner, Elizabeth O.;
    • Bromberg, Jacqueline F.;
    • DeMichele, Angela
    Publication type:
    Article
    12

    Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

    Published in:
    2018
    By:
    • Morris, Patrick G.;
    • Rota, Selene;
    • Cadoo, Karen;
    • Zamora, Stephen;
    • Patil, Sujata;
    • D'Andrea, Gabriella;
    • Gilewski, Theresa;
    • Bromberg, Jacqueline;
    • Chau Dang;
    • Dickler, Maura;
    • Modi, Shanu;
    • Seidman, Andrew D.;
    • Sklarin, Nancy;
    • Norton, Larry;
    • Hudis, Clifford A.;
    • Fornier, Monica N.;
    • Dang, Chau
    Publication type:
    journal article
    13

    First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 386, doi. 10.2967/jnumed.123.266392
    By:
    • Yeh, Randy;
    • O'Donoghue, Joseph A.;
    • Jayaprakasam, Vetri Sudar;
    • Mauguen, Audrey;
    • Min, Ryan;
    • Park, Sue;
    • Brockway, Julia P.;
    • Bromberg, Jacqueline F.;
    • Zhi, W. Iris;
    • Robson, Mark E.;
    • Sanford, Rachel;
    • Modi, Shanu;
    • Agnew, Brian J.;
    • Lyashchenko, Serge K.;
    • Lewis, Jason S.;
    • Ulaner, Gary A.;
    • Zeglis, Brian M.
    Publication type:
    Article
    14

    First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266392
    By:
    • Yeh, Randy;
    • O'Donoghue, Joseph A.;
    • Jayaprakasam, Vetri Sudar;
    • Mauguen, Audrey;
    • Min, Ryan;
    • Park, Sue;
    • Brockway, Julia P.;
    • Bromberg, Jacqueline F.;
    • Zhi, W. Iris;
    • Robson, Mark E.;
    • Sanford, Rachel;
    • Modi, Shanu;
    • Agnew, Brian J.;
    • Lyashchenko, Serge K.;
    • Lewis, Jason S.;
    • Ulaner, Gary A.;
    • Zeglis, Brian M.
    Publication type:
    Article
    15
    16
    17
    18

    Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.

    Published in:
    Nature Communications, 2015, v. 6, n. 4, p. 6840, doi. 10.1038/ncomms7840
    By:
    • Papaspyridonos, Marianna;
    • Matei, Irina;
    • Huang, Yujie;
    • do Rosario Andre, Maria;
    • Brazier-Mitouart, Helene;
    • Waite, Janelle C.;
    • Chan, April S.;
    • Kalter, Julie;
    • Ramos, Ilyssa;
    • Wu, Qi;
    • Williams, Caitlin;
    • Wolchok, Jedd D.;
    • Chapman, Paul B.;
    • Peinado, Hector;
    • Anandasabapathy, Niroshana;
    • Ocean, Allyson J.;
    • Kaplan, Rosandra N.;
    • Greenfield, Jeffrey P.;
    • Bromberg, Jacqueline;
    • Skokos, Dimitris
    Publication type:
    Article
    19

    Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

    Published in:
    Oncogene, 2002, v. 21, n. 13, p. 2000, doi. 10.1038/sj.onc.1205260
    By:
    • Niu, Guilian;
    • Wright, Kenneth L.;
    • Huang, Mei;
    • Song, Lanxi;
    • Haura, Eric;
    • Turkson, James;
    • Shumin Zhang;
    • Wang, Tianhong;
    • Sinibaldi, Dominic;
    • Coppola, Domenico;
    • Heller, Richard;
    • Ellis, Lee M.;
    • Karras, James;
    • Bromberg, Jacqueline;
    • Pardoll, Drew;
    • Jove, Richard;
    • Hua Yu
    Publication type:
    Article
    20
    21
    22
    23
    24

    Stat3 Mediates Expression of Autotaxin in Breast Cancer.

    Published in:
    PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027851
    By:
    • Azare, Janeen;
    • Doane, Ashley;
    • Leslie, Kenneth;
    • Chang, Qing;
    • Berishaj, Marjan;
    • Nnoli, Jennifer;
    • Mark, Kevin;
    • Al-Ahmadie, Hikmat;
    • Gerald, William;
    • Hassimi, Maryam;
    • Viale, Agnes;
    • Stracke, Mary;
    • Lyden, David;
    • Bromberg, Jacqueline
    Publication type:
    Article
    25

    Double-stranded DNA in exosomes: a novel biomarker in cancer detection.

    Published in:
    Cell Research, 2014, v. 24, n. 6, p. 766, doi. 10.1038/cr.2014.44
    By:
    • Thakur, Basant Kumar;
    • Zhang, Haiying;
    • Becker, Annette;
    • Matei, Irina;
    • Huang, Yujie;
    • Costa-Silva, Bruno;
    • Zheng, Yan;
    • Hoshino, Ayuko;
    • Brazier, Helene;
    • Xiang, Jenny;
    • Williams, Caitlin;
    • Rodriguez-Barrueco, Ruth;
    • Silva, Jose M;
    • Zhang, Weijia;
    • Hearn, Stephen;
    • Elemento, Olivier;
    • Paknejad, Navid;
    • Manova-Todorova, Katia;
    • Welte, Karl;
    • Bromberg, Jacqueline
    Publication type:
    Article
    26

    Oral minoxidil for late alopecia in cancer survivors.

    Published in:
    Breast Cancer Research & Treatment, 2024, v. 208, n. 3, p. 491, doi. 10.1007/s10549-024-07440-5
    By:
    • Kuo, Alyce Mei-Shiuan;
    • Reingold, Rachel E.;
    • Ketosugbo, Kwami F.;
    • Pan, Alexander;
    • Kraehenbuehl, Lukas;
    • Dusza, Stephen;
    • Gajria, Devika;
    • Lake, Diana E.;
    • Bromberg, Jacqueline F.;
    • Traina, Tiffany A.;
    • Fornier, Monica N.;
    • Gucalp, Ayca;
    • D'Alessandro, Brian M.;
    • Rotemberg, Veronica;
    • Dauscher, Megan;
    • Shapiro, Jerry;
    • Goldfarb, Shari B.;
    • Markova, Alina;
    • Lacouture, Mario E.
    Publication type:
    Article
    27

    Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.

    Published in:
    Breast Cancer Research & Treatment, 2022, v. 195, n. 3, p. 341, doi. 10.1007/s10549-022-06669-2
    By:
    • Walsh, Elaine M.;
    • Gucalp, Ayca;
    • Patil, Sujata;
    • Edelweiss, Marcia;
    • Ross, Dara S.;
    • Razavi, Pedram;
    • Modi, Shanu;
    • Iyengar, Neil M.;
    • Sanford, Rachel;
    • Troso-Sandoval, Tiffany;
    • Gorsky, Mila;
    • Bromberg, Jacqueline;
    • Drullinsky, Pamela;
    • Lake, Diana;
    • Wong, Serena;
    • DeFusco, Patricia Ann;
    • Lamparella, Nicholas;
    • Gupta, Ranja;
    • Tabassum, Tasmila;
    • Boyle, Leigh Ann
    Publication type:
    Article
    28

    Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 227, doi. 10.1007/s10549-020-05726-y
    By:
    • Wang, Diana G.;
    • Barrios, Dulce M.;
    • Blinder, Victoria S.;
    • Bromberg, Jacqueline F.;
    • Drullinsky, Pamela R.;
    • Funt, Samuel A.;
    • Jhaveri, Komal L.;
    • Lake, Diana E.;
    • Lyons, Tomas;
    • Modi, Shanu;
    • Razavi, Pedram;
    • Sidel, Michelle;
    • Traina, Tiffany A.;
    • Vahdat, Linda T.;
    • Lacouture, Mario E.
    Publication type:
    Article
    29